Data Advisory Board

The Data Advisory Board advises us on the development and delivery of our Research Data Strategy.

Through this strategy, we aim to realise the potential of the cancer research data that we fund through improved data sharing and data science approaches. Together we will create a research data ecosystem that best serves cancer research for the benefit of patients and the public.

Remit of the board

This board is a group of international experts who bring a unique perspective on oncology data science, including trends and advances. They help us to consider the unique role that Cancer Research UK can play in this space with advice spanning a wide range of topics and activities relevant to our work in research data, such as:

  • current and future data programmes and funding streams
  • computing and infrastructure
  • research data findability, accessibility, interoperability and reusability
  • training, careers and research capacity to carry out quality data science
  • patient and public involvement and engagement
  • therapeutic translation
  • community and culture
  • sustainability, including environmental
  • equality, diversity and inclusion

Members of the board

Image of a dark haired woman sat at a computer, smiling facing the camera

Bissan Al-Lazikani
Chair

Professor of Genomic Medicine
Director of Therapeutics Data Science, The University of Texas MD Anderson Cancer Center, USA

Image of a dark haired man wearing a collared shirt under a jumper

Hugo Aerts

Director of Artificial Intelligence in Medicine Program, Harvard University
Associate Professor, Harvard University, Dana-Farber Cancer Institute and Massachusetts General Brigham Hospital, USA
Full Professor, Maastricht University, Netherlands

Image of a smiling short haired man wearing glasses

Chris Carrigan

Patient Representative
Expert Data Adviser, use MY data

Image of a short haired man wearing a striped button down shirt

Michael Chapman

Director of Research and Clinical Trials, NHS England

Image of a short haired man wearing glasses, a collared shirt and a suit jacket against a green patterned background

Michael Cuthbert

Director, UK National Quantum Computing Centre

Image of a bearded man wearing glasses and a suit

David Ford

Professor of Informatics and Director of Population Data Science, Swansea University
Lead, SAIL Databank
Director, Administrative Data Research UK’s Centre for Wales

Image of a short haired smiling man

Chris Holmes

Professor of Biostatistics, University of Oxford

Image of a blonde, short-haired woman

Debbie Keatley

Patient Member, Cancer Research UK’s Clinical Research Committee and Experimental Medicine Expert Review Panel
Member, Health Data Research UK’s Public Advisory Board

Image of a smiling, short haired man wearing a navy suit

Martin Levermore

Founder and Chief Executive, MDTi
Commercial Advisor, PIONEER
Non-Executive Director and Chair of Digital, Implementation and Research, Royal Wolverhampton NHS Trust
Senior Association, Royal Society of Medicine
Visiting Professor for Health, Education and Life Sciences, Birmingham City University
UK Home Office Independent Person to advise on the Windrush Compensation Scheme

Image of a short haired man wearing a white collared shirt

Parker Moss

Executive Vice President Corporate Development, Exscientia
Non-Executive Director, Cancer Research Horizons

Image of a brown haired man facing the camera

Michael Parker

Ethox Centre Director and Professor of Bioethics, University of Oxford
Ethics Lead, Our Future Health

Image of a short haired smiling woman wearing a blue top with white polka dots under a cardigan

Cathie Sudlow

Director, British Heart Foundation Data Science Centre
Chief Scientist and Deputy Director, Health Data Research UK
Professor of Neurology and Clinical Epidemiology, University of Edinburgh
Honorary Consultant Neurologist, NHS Lothian (acute stroke service)

Data-driven cancer research conference

Join us on 27-28 February, 2024 for our inaugural data-driven cancer research conference to celebrate the potential of cancer research data to drive discovery and innovation.